Literature DB >> 28770359

Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Clare Meernik1, Anna McCullough2, Leah Ranney2, Barbara Walsh3, Adam O Goldstein2,4.   

Abstract

Though persons with behavioral health conditions experience large disparities in tobacco use, questions about the efficacy of evidence-based tobacco use treatment remain understudied in community health settings. This evaluation examined outcomes from eight community-based tobacco cessation programs for participants with and without behavioral health conditions (n = 974 participants). The majority (64.8%) of participants reported one or more current behavioral health conditions, including mental illness and/or substance abuse. Participants who used cessation medication during the program and who attended more counseling sessions had an increased likelihood of being quit at 4-month follow-up. Quit rates were between 9.8% (intent-to-treat rate) and 30.6% (responder rate); behavioral health status did not negatively affect reported quit rates. Findings add to the growing literature evaluating community-based interventions within the behavioral health population.

Entities:  

Keywords:  Behavioral counseling; Mental health; Smoking; Smoking cessation; Tobacco use cessation products

Mesh:

Year:  2017        PMID: 28770359     DOI: 10.1007/s10597-017-0155-2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  39 in total

1.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

2.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

3.  Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?

Authors:  Judith J Prochaska
Journal:  Drug Alcohol Depend       Date:  2010-04-07       Impact factor: 4.492

4.  Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Authors:  John A Stapleton; Lucy Watson; Lucy I Spirling; Robert Smith; Andrea Milbrandt; Marina Ratcliffe; Gay Sutherland
Journal:  Addiction       Date:  2007-11-19       Impact factor: 6.526

Review 5.  Nicotine interventions with comorbid populations.

Authors:  Sharon M Hall
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

6.  Smokers with behavioral health comorbidity should be designated a tobacco use disparity group.

Authors:  Jill M Williams; Marc L Steinberg; Kim Gesell Griffiths; Nina Cooperman
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

Review 7.  Assessing motivation to quit smoking in people with mental illness: a review.

Authors:  Ranita Siru; Gary K Hulse; Robert J Tait
Journal:  Addiction       Date:  2009-05       Impact factor: 6.526

8.  Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning.

Authors:  Judith J Prochaska; Sharon M Hall; Janice Y Tsoh; Stuart Eisendrath; Joseph S Rossi; Colleen A Redding; Amy B Rosen; Marc Meisner; Gary L Humfleet; Julie A Gorecki
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

9.  Quitline Use and Outcomes among Callers with and without Mental Health Conditions: A 7-Month Follow-Up Evaluation in Three States.

Authors:  Katrina A Vickerman; Gillian L Schauer; Ann M Malarcher; Lei Zhang; Paul Mowery; Chelsea M Nash
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

Review 10.  Change in mental health after smoking cessation: systematic review and meta-analysis.

Authors:  Gemma Taylor; Ann McNeill; Alan Girling; Amanda Farley; Nicola Lindson-Hawley; Paul Aveyard
Journal:  BMJ       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.